Abbott Cooper PLLC is investigating fiduciary duty claims for Kalaris Therapeutics (formerly AlloVir

Valuation and Earnings This table compares SQZ Biotechnologies and AlloVir"s gross revenue, earnings

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered L

Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Lo

NEW YORK, NY / ACCESS Newswire / June 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating

NEW YORK, NY / ACCESS Newswire / June 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating

BOSTON, June 05, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that the United States Di

NEW YORK, NY / ACCESS Newswire / June 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating

Kalaris is focused on developing TH103, a novel, differentiated anti-VEGF agent engineered to potent

Combined company expected to trade on Nasdaq under “KLRS” after closing Combined company expected to

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and th

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and th

NEW YORK, Nov. 09, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is invest

NEW YORK , Nov. 8, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigat

NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”)

The most oversold stocks in the health care presents an opportunity to buy into undervalued companie

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

  During Tuesday's session, 275 companies made new 52-week lows.

U.S. stocks traded higher, with the Dow Jones falling around 180 points on Friday. Here are some big

  During Monday's session, 201 stocks hit new 52-week lows.

Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the comp

Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signe

Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media S

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednes

Gainers

  On Wednesday, 807 companies reached new 52-week lows.

    On Monday, 721 companies achieved new lows for the year.

  On Friday, 431 companies hit new 52-week lows.

    On Monday, 466 companies hit new 52-week lows.

  On Monday, 78 companies set new 52-week lows.

  During Thursday's morning trading, 152 companies set new 52-week lows.

    During Wednesday's morning trading, 400 companies set new 52-week lows.

  Tuesday morning saw 454 companies set new 52-week lows.

    On Thursday, 615 stocks hit new 52-week lows.

    On Monday morning, 60 companies achieved new lows for the year.

  During the morning session on Thursday, 152 stocks hit new 52-week lows.

    Thursday morning, 158 companies reached new 52-week lows.

    During Thursday's morning session, 92 stocks hit new 52-week lows.

Gainers Cassava Sciences, Inc. (NASDAQ: SAVA) shares jumped 34.6% to $9.54 following news of two

Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares jumped 171.6% to close at $34.22 on Monda

Gainers